Mutual of America Capital Management LLC trimmed its position in Moderna, Inc. (NASDAQ:MRNA – Free Report) by 2.6% during the ...

Moderna (NASDAQ:MRNA) shares about 3% ahead of Wednesday market open after Goldman Sachs (NYSE:GS) cut its rating on the stock to Neutral from Buy. The downgrade follows a series of negative ...

“S&P 500 annual return dispersion in 2024 rose to 70 percentage points, the highest level outside of recessions since 2007,” David Kostin, strategist at Goldman Sachs ... 20.5 Moderna Inc ...

The second group, so-called "Constrained Losers," are those hard-to-short stocks that have lost the most over the trailing year. The professors found that these stocks also lag the market, but for a ...

This is a significant shift from the previous quarter when Moderna’s Q3 2024 results showcased resilience. Goldman Sachs Weighs in on Moderna Stock While Moderna’s Q4 earnings may represent a ...

Moderna Inc. recorded another quarterly loss as vaccine sales wane and the company had an unexpected charge for canceled manufacturing contract. Goldman Sachs US Biotechnology Analyst Salveen ...

Moderna reports larger-than-expected quarterly ... sources say 4:47 AM UTC · Updated ago Financecategory Goldman Sachs raises 2025 economic growth forecast for Germany, Euro area 4:42 AM UTC ...

3 analysts have bearish recommendations on Moderna, while 2 analysts have bullish ratings. The street high price target from Goldman Sachs is $99.0, while the street low from B of A Securities is ...

In addition to RBC Capital, Moderna also received a Hold from Goldman Sachs’s Salveen Richter in a report issued on February 14. However, on the same day, Wolfe Research reiterated a Sell rating ...

Moderna (NASDAQ:MRNA ... Revenue estimates have seen 2 upward revisions and 8 downward. Goldman Sachs says, “We recognize that there are pipeline levers that could contribute to the top line ...

Nutanix jumped 14% after posting fiscal second-quarter earnings and revenue that beat analysts' forecasts. Nvidia reported sharply higher quarterly sales and profit, but a narrower profit margin.

Goldman, Sachs & Co. LLC served as financial advisor to RGA ... Farmers and agribusinesses will gain access to a Bushel business account*, offered by... mRESVIA® is Moderna's second approved ...